Investors impatient for Alzheimer's cure - MarketWatch
Por um escritor misterioso
Descrição
Investors show signs of impatience about drugs that are being tested as a treatment for Alzheimer’s disease.
Scailyte Closes Series A Funding With a CHF 6 Million Investment
Senior Resources - Jones County
Disney CEO Bob Iger walks back comments about asset sales
Press Columbia University Mailman School of Public Health
Nvidia, Disney and Tesla are among 2023's buzziest stocks. Can
Gratitude Through Hard Times – Podcast – Podtail
Tools for Change – September 2023
Tracing investment in drug development for Alzheimer disease
How to invest in the fight against Alzheimer's disease
Your Edge In Biotech
de
por adulto (o preço varia de acordo com o tamanho do grupo)
